Shanghai Ruishi Health Technology Co., Ltd. announced that it has raised CNY 100 million in an equity funding led by new investor, Sinovation Ventures (Beijing) Enterprise Management Limited on August 9, 2023. The transaction included participation from new investor, Yunnan Botanee Bio-Technology Group Co.LTD, returning investors, BRV Partners, LLC and Yaojin (Shanghai) Private Equity Fund Management Co., Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
57.3 CNY | +3.52% | +2.08% | -15.95% |
Apr. 29 | Jefferies Adjusts Yunnan Botanee Bio-Technology’s Price Target to 62 Yuan From 87 Yuan, Keeps at Hold | MT |
Apr. 26 | Yunnan Botanee Bio-Technology Group Co.LTD Proposes Final Dividend for 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.95% | 3.33B | |
+12.50% | 18.94B | |
0.00% | 17.84B | |
-0.87% | 10.7B | |
-7.25% | 10.31B | |
+7.52% | 6.95B | |
+10.34% | 5.98B | |
-0.06% | 4.56B | |
-18.21% | 3.77B | |
-4.56% | 3.58B |
- Stock Market
- Equities
- 300957 Stock
- News Yunnan Botanee Bio-Technology Group Co.LTD
- Shanghai Ruishi Health Technology Co., Ltd. announced that it has received CNY 100 million in funding from BRV Partners, LLC, Yaojin Private Equity Fund Management Co., Ltd., Sinovation Ventures Enterprise Management Limited, Yunnan Botanee Bio-Technology Group Co.LTD